Cencora Inc.
- Industrie
- Pharmaceutical Distribution
- Bourse
- États-Unis
- Pays / Région
- USA
- Date d'introduction en bourse
- 4 avril 1995
- Effectif
- 47 000
- Site web
- www.cencora.com
Fourchette de valorisation composite · prudent $205–$235 / raisonnable $250–$300 / optimiste $320–$350. À $311.15, Entre la fourchette raisonnable et la fourchette optimiste.
À la publication $270.78 (27 mai 2026)
Données EODHD, présentées dans la devise de reporting ; à titre indicatif uniquement, ne constitue pas un conseil en investissement.
Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes generic and injectable pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; distributes plasma and other blood products, vaccines, and other specialty pharmaceutical products; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and other services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; sales force services to manufacturers; and offers other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment provides international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals; and offers specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was founded in 1871 and is headquartered in Conshohocken, Pennsylvania.
Historique
Cencora, Inc. was founded in 1871 and is headquartered in Conshohocken, Pennsylvania. It carries an IPO date of April 4, 1995. In 2020, the company recognized a $6.6 billion legal accrual related to opioid matters. Formerly known as AmerisourceBergen Corporation, it changed its name to Cencora, Inc. in August 2023. In 2026, to fund the OneOncology transaction, the company issued $3 billion of senior notes and a $1.5 billion term loan.
Position dans le secteur
Cencora sources and distributes pharmaceutical products in the United States and internationally, and is one of three large national pharmaceutical wholesalers in the U.S. FY2025 revenue was $321.3 billion, reported across two segments: U.S. Healthcare Solutions (about $285 billion) and International Healthcare Solutions (about $28.3 billion), plus roughly $8.2 billion in Other (including MWI Animal Health, Profarma, and PharmaLex). It employs about 47,000 people. Its strongest peers are McKesson (FY2025 revenue $359.1 billion) and Cardinal Health (FY2025 revenue $222.6 billion).
Pas encore d'analyse sur cette valeur dans votre langue.